{"@context":{"@vocab":"https://schema.org/"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/fda/warning-letters/check?name=Profounda%2C%20Inc.","name":"Profounda, Inc.","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters","generated_at":"2026-11-03T11:57:51.042Z"},"count":1,"matches":[{"id":"6dbbf6256ccdfa34","posted_date":"2023-03-14","letter_issue_date":"2023-02-01","company_name":"Profounda, Inc.","issuing_office":"Division of Pharmaceutical Quality Operations II","subject":"CGMP/Finished Pharmaceuticals/Adulterated","canonical_url":"https://api.morvs.ai/fda-warning/6dbbf6256ccdfa34"}]}